Evidence map›Paper›PMID 40443259›Full record

ReviewESC heart failure2025

Celebrating a decade of the HFA young community: Achievements and future directions by the HFA Young Committee.

Mateusz Sokolski, Emanuele Bobbio, Alberto Esteban-Fernandez, Sotiria Liori, Cornelia Margineaunu, Francesca Musella, Chris J Kapelios, Henrike Arfsten, Shirley Sze, Daniela Tomasoni and 9 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ESC heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Mateusz SokolskiInstitute of Heart Diseases, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.ORCID https://orcid.org/0000-0001-9925-3566
Emanuele BobbioInstitute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Alberto Esteban-FernandezCardiology Department, University Hospital Severo Ochoa, Madrid, Spain.
Sotiria LioriSecond Department of Cardiology, Attikon University Hospital, Athens, Greece.
Cornelia MargineaunuUniversity of Medicine Carol Davila, Bucharest, Romania.
Francesca MusellaDivision of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Chris J KapeliosSecond Department of Cardiology, Attikon University Hospital, Athens, Greece.
Henrike ArfstenDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Shirley SzeNIHR Leicester Biomedical Research Centre, University of Leicester, Glenfield Hospital Groby Road, Leicester, UK.
Daniela TomasoniInstitute of Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Han Naung TunLarner College of Medicine, University of Vermont, Burlington, Vermont, USA.
Markus WallnerDepartment of Internal Medicine, Division of Cardiology, Medical University of Graz, Graz, Austria.
Brenda MouraHospital das Forças Armadas and Cintesis, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Ewa A JankowskaInstitute of Heart Diseases, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
Alexandre MebazaaUniversité de Paris, MASCOT, INSERM, Paris, France.
Marco MetraCardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Wilfried MullensHospital Oost-Limburg, Genk, Belgium.
Jozine M Ter MaatenUniversity of Groningen, Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
Antonio CannataSchool of Cardiovascular Medicine and Sciences, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Heart Failure Association (HFA) Young initiative, established in 2014, welcomes all HFA members under 40 years of age, including physicians, scientists, nurses and allied health professionals. Its primary aim is to foster the growth of the next generation of heart failure (HF) specialists through a variety of educational and career-building programmes such as the monthly HFA Cardiotalk Podcast, the quarterly HFA Journal Club and the Career Café. The members also have the possibility to participate in the construction of the annual HFA congress programme and benefit from travel grants for the HFA Congress, and networking events at scientific meetings. In 2022-2023, the HFA Young conducted a survey that garnered 305 members, giving an important snapshot of their needs, expectations and aspirations, which served as a roadmap for the priorities of the group. Finally, in order to build and maintain networks of young professionals at the national level, the HFA Young Ambassadors initiative was established, connecting the HFA Young Committee with young HF professionals in their respective countries. This initiative has proven to be crucial for building a global community of emerging HF specialists and enhancing the awareness of the HFA's activities. The article presents the evolution of HFA Young over the past 10 years, summarizes key activities and survey results and seeks to outline future development directions.

Indexed as

CardiologyHeart FailureSocieties, MedicalAdultHumansHeart failureHeart Failure AssociationHeart Failure Association YoungHFA survey

Identifiers

PMID40443259
PMCPMC12287769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.